Congestive heart failure adherence redesign trial: a pilot study.

ABSTRACT:

Objective

Heart failure (HF) continues to be a leading cause of hospital admissions, particularly in underserved patients. We hypothesised that providing individualised self-management support to patients and feedback on use of evidence-based HF therapies (EBT) to physicians could lead to improvements in care and decrease hospitalisations. To assess the feasibility of conducting a larger trial testing the efficacy of this dual-level intervention, we conducted the Congestive Heart failure Adherence Redesign Trial Pilot (CHART-P), a proof-of-concept, quasi-experimental, feasibility pilot study.

Setting

A large tertiary care medical centre in Chicago.

Participants

Low-income patients (

SUBMITTER: Mangla A 

PROVIDER: S-EPMC4256535 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature